- Executives at Johnson & Johnson's (JNJ -0.6%) $28.5B Medical Devices and Diagnostics segment meet with institutional investors today discuss the business and outline their plans to drive global growth.
- Key points include: ~$1.8B in R&D investments last year; a pipeline of more than 30 major product filings by the end of 2016; $6B in device sales; acquisition of Spectrum Vision enables the delivery of more than 85% of Acuvue contact lenses the same day or next day across all time zones in Russia; China operations grew 18% last year to $1.4B.
- Webcast info
J&J segment has big plans to expand its market leadership
From other sites
at Financial Times (Wed, 4:54AM)
at Nasdaq.com (Apr 27, 2015)
at Investopedia (Apr 10, 2015)
at 4-traders.com (Mar 24, 2015)
at Nasdaq.com (Mar 16, 2015)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs